Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Color
AddedFeb 13, 2024
UpdatedJun 18, 2026
Color

Color

Series E

Color: A health tech firm providing genetic tests for disease risk and medication response analysis.

HQ
Burlingame, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Color is a population health technology company founded with the mission to democratize access to genetic testing and health information. The company provides genetic tests and analysis directly to patients and through employers, focusing on genes that indicate risks for heart disease, cancer, and medication response. Color aims to empower individuals with actionable health insights, thereby improving overall health outcomes and preventive care. Their market focus includes employers, health plans, unions, clinicians, and individuals.

Notable figures associated with Color include its leadership team, which comprises experts in genetics, healthcare, and technology. The company has secured investments from prominent venture capital firms, contributing to its rapid growth and innovation in the health tech space. Key achievements include forming partnerships with organizations like Bexa and SkinIO for distributed screening solutions. Color's impact is seen in its contribution to personalized medicine and preventive healthcare, making genetic testing more accessible and actionable for diverse populations.

Color - Similar Companies

Invitae logo

Invitae

invitae.com

23andMe logo

23andMe

23andme.com

Genetica logo

Genetica

genetica.asia

Pathway Genomics logo

Pathway Genomics

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Geneticure logo

Geneticure

geneticure.com

Colour Health logo

Colour Health

Fulgent Genetics logo

Fulgent Genetics

Allelica logo

Allelica

allelica.com

Myriad Genetics logo

Myriad Genetics

myriad.com

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Visible Genomics logo

Visible Genomics

visiblegenomics.io

Geneicd logo

Geneicd

Sequencing.com logo

Sequencing.com

sequencing.com

Informeddna logo

Informeddna

informeddna.com

Color - Quick Facts

Who are Color's competitors?

Companies similar to Color include Invitae, 23andMe, Genetica and Pathway Genomics.

When was Color founded?

Color was founded in 2015.

Where is Color's headquarters located?

Color's headquarters is located in Burlingame, CA, US.

When was Color's last funding round?

Color's most recent funding round was for $100M (USD) in November 2021.

How much has Color raised to-date?

As of Nov 9, 2021, Color has raised a total of $482M (USD).

How many employees does Color have?

Color has 474 employees as of Feb 5, 2024.

Color - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Genetic Testing
  • Health Information
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research